Semler Scientific Inc.

Case Overview
40 Days Left to Seek Lead Plaintiff
Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 10/28/2025 |
Status: | Status: Investigating |
Company Name: | Company Name: Semler Scientific Inc. |
Court: | Court: Northern District of California |
Case Number: | Case Number: 5:25cv07303 |
Class Period: | Class Period: 03/10/2021 - 04/15/2025 |
Ticker: | Ticker: SMLR |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Semler Scientific, Inc. (“Semler” or the “Company”) (NASDAQ:SMLR) securities during the period of March 10, 2021 through April 15, 2025, inclusive (“the Class Period”).
On February 28, 2025, Semler filed its Form 10-K with the SEC and therein, disclosed that the Company received an initial civil investigative demand from the U.S. Department of Justice in July 2017 regarding Semler’s claims for reimbursement related to the QuantaFlo device. Semler received subsequent requests for information in February 2019, December 2021, April 2022, and April 2023. In February 2025, Semler participated in settlement discussions with the DOJ, which were unsuccessful. The Company disclosed that “there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages.” On this news, the price of Semler shares declined by $4.03 per share, or approximately 9.39%, from $42.92 per share on February 28, 2025 to close at $38.89 on March 3, 2025.
Then, on April 15, 2025, Semler Scientific revealed that it “reached agreement in principle on payment of $29.75 million to settle all claims (which amount excludes any potential relator counsel fees that may also be payable),” according to the complaint. On this news, the price of Semler shares declined by $3.40 per share, or approximately 9.9%, from $34.40 per share on April 15, 2025 to close at $31.00 on April 16, 2025.
On February 28, 2025, Semler filed its Form 10-K with the SEC and therein, disclosed that the Company received an initial civil investigative demand from the U.S. Department of Justice in July 2017 regarding Semler’s claims for reimbursement related to the QuantaFlo device. Semler received subsequent requests for information in February 2019, December 2021, April 2022, and April 2023. In February 2025, Semler participated in settlement discussions with the DOJ, which were unsuccessful. The Company disclosed that “there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages.” On this news, the price of Semler shares declined by $4.03 per share, or approximately 9.39%, from $42.92 per share on February 28, 2025 to close at $38.89 on March 3, 2025.
Then, on April 15, 2025, Semler Scientific revealed that it “reached agreement in principle on payment of $29.75 million to settle all claims (which amount excludes any potential relator counsel fees that may also be payable),” according to the complaint. On this news, the price of Semler shares declined by $3.40 per share, or approximately 9.9%, from $34.40 per share on April 15, 2025 to close at $31.00 on April 16, 2025.
The lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose a material investigation by the United States Department of Justice (the "DOJ") into violations of the False Claims Act, while discussing possible violations of the False Claims (and aggressive DOJ enforcement thereof) in hypothetical terms. When the true details entered the market, the lawsuit claims that investors suffered damages.